482 related articles for article (PubMed ID: 26338314)
21. [Results and cost-effectiveness of colorectal cancer screening program among urban residents in Zhejiang province, 2013-2018].
Wang L; Li HZ; Zhu C; Wang YQ; Zhou HJ; Sun XH; Zhang MZ; Jin L; Du LB
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):2080-2086. PubMed ID: 33378820
[No Abstract] [Full Text] [Related]
22. Cost-effectiveness of high-sensitivity faecal immunochemical test and colonoscopy screening for colorectal cancer.
Aronsson M; Carlsson P; Levin LÅ; Hager J; Hultcrantz R
Br J Surg; 2017 Jul; 104(8):1078-1086. PubMed ID: 28561259
[TBL] [Abstract][Full Text] [Related]
23. Screening based on risk for colorectal cancer is the most cost-effective approach.
Dan YY; Chuah BY; Koh DC; Yeoh KG
Clin Gastroenterol Hepatol; 2012 Mar; 10(3):266-71.e1-6. PubMed ID: 22100624
[TBL] [Abstract][Full Text] [Related]
24. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia.
de Wijkerslooth TR; Stoop EM; Bossuyt PM; Meijer GA; van Ballegooijen M; van Roon AH; Stegeman I; Kraaijenhagen RA; Fockens P; van Leerdam ME; Dekker E; Kuipers EJ
Am J Gastroenterol; 2012 Oct; 107(10):1570-8. PubMed ID: 22850431
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness and budget impact analysis of a population-based screening program for colorectal cancer.
Pil L; Fobelets M; Putman K; Trybou J; Annemans L
Eur J Intern Med; 2016 Jul; 32():72-8. PubMed ID: 27157827
[TBL] [Abstract][Full Text] [Related]
26. An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme.
Kelley L; Swan N; Hughes DJ
Colorectal Dis; 2013 Sep; 15(9):e512-21. PubMed ID: 23746062
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness modeling of colorectal cancer: computed tomography colonography vs colonoscopy or fecal occult blood tests.
Lucidarme O; Cadi M; Berger G; Taieb J; Poynard T; Grenier P; Beresniak A
Eur J Radiol; 2012 Jul; 81(7):1413-9. PubMed ID: 21444171
[TBL] [Abstract][Full Text] [Related]
28. Lower Abnormal Fecal Immunochemical Test Cut-Off Values Improve Detection of Colorectal Cancer in System-Level Screens.
Berry E; Miller S; Koch M; Balasubramanian B; Argenbright K; Gupta S
Clin Gastroenterol Hepatol; 2020 Mar; 18(3):647-653. PubMed ID: 31085338
[TBL] [Abstract][Full Text] [Related]
29. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy.
Parente F; Boemo C; Ardizzoia A; Costa M; Carzaniga P; Ilardo A; Moretti R; Cremaschini M; Parente EM; Pirola ME
Endoscopy; 2013; 45(1):27-34. PubMed ID: 23254404
[TBL] [Abstract][Full Text] [Related]
30. Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program.
Chiu SY; Chuang SL; Chen SL; Yen AM; Fann JC; Chang DC; Lee YC; Wu MS; Chou CK; Hsu WF; Chiou ST; Chiu HM
Gut; 2017 Feb; 66(2):293-300. PubMed ID: 26515543
[TBL] [Abstract][Full Text] [Related]
31. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
[TBL] [Abstract][Full Text] [Related]
32. A New-Generation Fecal Immunochemical Test (FIT) Is Superior to Quaiac-based Test in Detecting Colorectal Neoplasia Among Colonoscopy Referral Patients.
Vasilyev S; Smirnova E; Popov D; Semenov A; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
Anticancer Res; 2015 May; 35(5):2873-80. PubMed ID: 25964570
[TBL] [Abstract][Full Text] [Related]
33. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing.
Wong CK; Lam CL; Wan YF; Fong DY
BMC Cancer; 2015 Oct; 15():705. PubMed ID: 26471036
[TBL] [Abstract][Full Text] [Related]
35. Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme.
Peng SM; Hsu WF; Wang YW; Lin LJ; Yen AM; Chen LS; Lee YC; Wu MS; Chen TH; Chiu HM
Gut; 2021 Jul; 70(7):1318-1324. PubMed ID: 32989019
[TBL] [Abstract][Full Text] [Related]
36. Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare.
Ladabaum U; Mannalithara A; Brill JV; Levin Z; Bundorf KM
Am J Gastroenterol; 2018 Dec; 113(12):1836-1847. PubMed ID: 29904156
[TBL] [Abstract][Full Text] [Related]
37. One-sample quantitative and two-sample qualitative faecal immunochemical tests for colorectal cancer screening: a cross-sectional study in China.
Wang L; Chen H; Zhu Y; Lu M; Wang Y; Chen X; Ma W; Du L; Chen W
BMJ Open; 2022 May; 12(5):e059754. PubMed ID: 35589365
[TBL] [Abstract][Full Text] [Related]
38. Fecal immunochemical test accuracy in familial risk colorectal cancer screening.
Castro I; Cubiella J; Rivera C; González-Mao C; Vega P; Soto S; Hernandez V; Iglesias F; Teresa Alves M; Bujanda L; Fernández-Seara J
Int J Cancer; 2014 Jan; 134(2):367-75. PubMed ID: 23818169
[TBL] [Abstract][Full Text] [Related]
39. Can colonoscopy remain cost-effective for colorectal cancer screening? The impact of practice patterns and the Will Rogers phenomenon on costs.
Austin GL; Fennimore B; Ahnen DJ
Am J Gastroenterol; 2013 Mar; 108(3):296-301. PubMed ID: 23208273
[TBL] [Abstract][Full Text] [Related]
40. Screening strategies for colorectal cancer among patients with nonalcoholic fatty liver disease and family history.
Wong MC; Ching JY; Chan VC; Lam TY; Luk AK; Wong SH; Ng SC; Wong VW; Ng SS; Wu JC; Chan FK; Sung JJ
Int J Cancer; 2016 Feb; 138(3):576-83. PubMed ID: 26289421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
